EVEREST ORGANICS
Back to Balance Sheet
|
EVEREST ORGANICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹15 Cr | ₹21 Cr | ₹18 Cr | ₹19 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of EVEREST ORGANICS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹15 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹18 Cr |
| Mar2022 | ₹19 Cr |
| Mar2021 | ₹11 Cr |
How is Total Non-Current Liabilities of EVEREST ORGANICS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹15 Cr | -29.69 | |
| Mar2024 | ₹21 Cr | 15.12 | |
| Mar2023 | ₹18 Cr | -3.16 | |
| Mar2022 | ₹19 Cr | 62.92 | |
| Mar2021 | ₹11 Cr | - | |
Compare Total Non-Current Liabilities of peers of EVEREST ORGANICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EVEREST ORGANICS | ₹299.4 Cr | -0.2% | 2.3% | -7.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
EVEREST ORGANICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EVEREST ORGANICS | -0.2% |
2.3% |
-7.2% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses